Ubs Group Ag Kura Oncology, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 139,525 shares of KURA stock, worth $817,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,525
Previous 315,475
55.77%
Holding current value
$817,616
Previous $2.75 Million
66.51%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$45.4 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$43.6 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$40.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$38.5 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$29 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $392M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...